GlucocorticoidsAntineoplastic AgentsDexamethasoneAntineoplastic Agents, PhytogenicLeukemia P388Amaryllidaceae AlkaloidsNarcissusEllipticinesBibenzylsReceptors, GlucocorticoidDoxorubicinDrug Screening Assays, AntitumorAntibiotics, AntineoplasticThiadiazinesBryostatinsAntineoplastic Agents, AlkylatingTumor Cells, CulturedAncitabineNeoplasmsGalliumDrug SynergismApoptosisDepsipeptidesMifepristoneCisplatinPaclitaxel6-MercaptopurineCell Line, TumorCell SurvivalAminoacridinesEpothilonesDose-Response Relationship, DrugCorticosteroneMolecular StructureSarcoma 180AdrenalectomyHydrocortisoneLactonesLeukemia L1210Antimetabolites, AntineoplasticDaunorubicinCell DivisionFluorouracilRNA, MessengerBleomycinDrug ResistanceDrug Resistance, NeoplasmDrug Evaluation, PreclinicalEtoposideAntineoplastic Combined Chemotherapy ProtocolsProdrugsDrug EvaluationXenograft Model Antitumor AssaysMethotrexateCell LineNeoplasms, ExperimentalCells, Cultured11-beta-Hydroxysteroid Dehydrogenase Type 1Time FactorsEnzyme InhibitorsCell Cycle11-beta-Hydroxysteroid DehydrogenasesMacrolidesCell ProliferationCamptothecinHormone AntagonistsStilbenesDrug Administration ScheduleDrug InteractionsPrednisolone11-beta-Hydroxysteroid Dehydrogenase Type 2KineticsMice, NudeHL-60 CellsLung NeoplasmsCortisoneVincristineAnti-Inflammatory AgentsNeoplasm TransplantationIsoquinolinesBiotransformationCyclophosphamideBreast NeoplasmsDNADNA DamageClinical Trials as TopicLeukemiaBetamethasoneStereoisomerismTriamcinoloneCaspasesOvarian NeoplasmsHydroxysteroid DehydrogenasesPituitary-Adrenal SystemColonic NeoplasmsHypothalamo-Hypophyseal SystemTaxoidsMethylprednisoloneProstatic NeoplasmsGene Expression Regulation